PAVM - Latest News
PAVmed Inc. (PAVM), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $3.4M. Trailing twelve-month P/E ratio is 12.17. Beta to the broader market is 0.64.
The article list below shows the most recent PAVM headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent PAVM Headlines
PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 15, 2026
PAVmed Inc.
PAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue Estimates
zacks.com - May 15, 2026
PAVmed Inc. (PAVM) came out with a quarterly loss of $1.
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
prnewswire.com - May 15, 2026
Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission Lucid Diagnostics contin
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results
prnewswire.com - May 14, 2026
Processed 3,177 EsoGuard ® tests and recognized 1Q26 revenue of $1. 3 million, ending quarter with $45 million in proforma cash and a runway that exte
Will PAVmed Inc. (PAVM) Report Negative Earnings Next Week? What You Should Know
zacks.com - May 8, 2026
PAVmed (PAVM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t
How News Affects PAVM Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PAVM's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked PAVM news questions
- What is the latest PAVM news headline?
- The most recent PAVM headline (May 15, 2026) is "PAVmed Inc. (PAVM) Q1 2026 Earnings Call Transcript". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the PAVM news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What PAVM news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual PAVM options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.